|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Omega Healthcare Investors insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Omega Healthcare Investors insider buys are important for investors to follow.
Date | Insider | Price | Amount |
11-16-2021 Insider Buy |
Gail D. Makode Chief Legal Officer |
$28.73
CAGR »
|
$28,730.00 1,000 shares |
11-15-2021 Insider Buy |
Kapila K. Anand Director |
$28.32
CAGR »
|
$28,317.60 1,000 shares |
10-1-2021 Insider Buy |
Neal Ballew Chief Accounting Officer |
$29.96
CAGR »
|
$9,257.64 309 shares |
9-1-2021 Insider Buy |
Burke W. Whitman Director |
$33.65
CAGR »
|
$16,825.00 500 shares |
7-1-2021 Insider Buy |
Neal Ballew Chief Accounting Officer |
$36.29
CAGR »
|
$9,253.95 255 shares |
8-2-2021 Insider Buy |
Burke W. Whitman Director |
$36.50
CAGR »
|
$18,250.00 500 shares |
7-1-2021 Insider Buy |
Burke W. Whitman Director |
$36.30
CAGR »
|
$18,150.00 500 shares |
6-1-2021 Insider Buy |
Burke W. Whitman Director |
$36.96
CAGR »
|
$18,480.00 500 shares |
5-3-2021 Insider Buy |
Burke W. Whitman Director |
$38.16
CAGR »
|
$19,080.00 500 shares |
4-1-2021 Insider Buy |
Burke W. Whitman Director |
$37.08
CAGR »
|
$18,540.00 500 shares |
3-1-2021 Insider Buy |
Burke W. Whitman Director |
$37.97
CAGR »
|
$18,985.00 500 shares |
2-1-2021 Insider Buy |
Burke W. Whitman Director |
$36.34
CAGR »
|
$18,170.00 500 shares |
1-4-2021 Insider Buy |
Burke W. Whitman Director |
$36.63
CAGR »
|
$18,315.00 500 shares |
12-1-2020 Insider Buy |
Burke W. Whitman Director |
$36.10
CAGR »
|
$18,050.00 500 shares |
11-2-2020 Insider Buy |
Burke W. Whitman Director |
$28.96
CAGR »
|
$14,480.00 500 shares |
10-1-2020 Insider Buy |
Burke W. Whitman Director |
$29.97
CAGR »
|
$14,985.00 500 shares |
9-1-2020 Insider Buy |
Burke W. Whitman Director |
$30.60
CAGR »
|
$15,300.00 500 shares |
8-3-2020 Insider Buy |
Burke W. Whitman Director |
$31.80
CAGR »
|
$15,900.00 500 shares |
7-1-2020 Insider Buy |
Burke W. Whitman Director |
$29.86
CAGR »
|
$14,930.00 500 shares |
6-1-2020 Insider Buy |
Burke W. Whitman Director |
$31.73
CAGR »
|
$25,384.00 800 shares |
3-16-2020 Insider Buy |
Craig R. Callen Director |
$19.53
CAGR »
|
$97,650.00 5,000 shares |
3-12-2020 Insider Buy |
Craig R. Callen Director |
$25.56
CAGR »
|
$102,240.00 4,000 shares |
2-14-2019 Insider Buy |
Burke W. Whitman Director |
$36.68
CAGR »
|
$49,512.19 1,350 shares |
12-22-2017 Insider Buy |
Bernard J. Korman Director |
$26.89
CAGR »
|
$2,689,000.00 100,000 shares |
11-2-2017 Insider Buy |
Craig R. Callen Director |
$27.38
CAGR »
|
$273,800.00 10,000 shares |
10-31-2017 Insider Buy |
Bernard J. Korman Director |
$28.24
CAGR »
|
$2,823,890.00 100,000 shares |
6-2-2017 Insider Buy |
Craig R. Callen Director |
$31.40
CAGR »
|
$471,037.50 15,000 shares |
11-4-2016 Insider Buy |
C. Taylor Pickett Chief Executive Officer |
$29.26
CAGR »
|
$637,881.08 21,800 shares |
5-23-2016 Insider Buy |
Thomas F. Franke Director |
$31.01
CAGR »
|
$186,059.80 6,000 shares |
2-12-2016 Insider Buy |
Thomas F. Franke Director |
$28.62
CAGR »
|
$457,984.40 16,000 shares |
11-16-2015 Insider Buy |
C. Taylor Pickett Chief Executive Officer |
$32.56
CAGR »
|
$136,772.16 4,200 shares |
5-5-2015 Insider Buy |
Bernard J. Korman Director |
$35.99
CAGR »
|
$3,599,500.00 100,000 shares |
5-29-2013 Insider Buy |
Craig R. Callen Director |
$32.31
CAGR »
|
$32,308.00 1,000 shares |
5-23-2013 Insider Buy |
Craig R. Callen Director |
$34.69
CAGR »
|
$69,370.00 2,000 shares |
5-10-2012 Insider Buy |
Bernard J. Korman Director |
$21.51
CAGR »
|
$130,137.01 6,050 shares |
5-9-2011 Insider Buy |
Bernard J. Korman Director |
$21.30
CAGR »
|
$118,726.20 5,574 shares |
Also See: Institutional Holders of OHI
Also See: SEC filings
Below we present the annualized performance delivered by Omega Healthcare Investors stock since 11-16-2021 (the date of the most recent
insider purchase). The performance of the investment from the time Omega Healthcare Investors insider buying occurred is the ultimate
test of whether insiders were right about OHI being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
11/17/2021 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$29.45 |
|
End price/share: |
$31.34 |
|
Starting shares: |
339.56 |
|
Ending shares: |
425.96 |
|
Dividends reinvested/share: |
$6.70 |
|
Total return: |
33.50% |
|
Average Annual Total Return: |
12.47% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$13,348.25 |
|
Years: |
2.46 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/17/2021 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$29.45 |
|
End price/share: |
$31.34 |
|
Dividends collected/share: |
$6.70 |
|
Total return: |
29.17% |
|
Average Annual Total Return: |
10.98% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12,917.86 |
|
Years: |
2.46 |
|
Omega Healthcare Investors Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Omega Healthcare Investors insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding OHI
|
|